BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6515418)

  • 1. Performance characteristics of a simple radioimmunoassay for fibrinopeptide A.
    Walenga JM; Hoppensteadt D; Emanuele RM; Fareed J
    Semin Thromb Hemost; 1984 Oct; 10(4):219-27. PubMed ID: 6515418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a commercial kit for the radioimmunoassay of fibrinopeptide A.
    Butt RW; deBoer AC; Turpie AG
    J Immunoassay; 1984; 5(3-4):245-66. PubMed ID: 6530485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and performance characteristics of a competitive enzyme immunoassay for fibrinopeptide A.
    Amiral J; Walenga JM; Fareed J
    Semin Thromb Hemost; 1984 Oct; 10(4):228-42. PubMed ID: 6393350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of fibrinopeptide A as an indicator for coagulative analysis in thrombotic diseases].
    Murakoshi T
    Hokkaido Igaku Zasshi; 1982 May; 57(3):351-63. PubMed ID: 6957368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of automation on the quantitation of low molecular weight markers of hemostatic defects.
    Fareed J; Walenga JM; Bick RL; Bermes EJ; Messmore HL
    Semin Thromb Hemost; 1983 Oct; 9(4):355-79. PubMed ID: 6229030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A method for the assay of fibrinopeptide in plasma].
    Piana A; Armani U; Saccarello A; Boeri D; Maiello M; Falzetti G
    Boll Soc Ital Biol Sper; 1983 Oct; 59(10):1558-61. PubMed ID: 6661319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of fibrinopeptide A in human blood.
    Nossel HL; Yudelman I; Canfield RE; Butler VP; Spanondis K; Wilner GD; Qureshi GD
    J Clin Invest; 1974 Jul; 54(1):43-53. PubMed ID: 4600045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of fibrinopeptide A in surgery].
    Fuwa S
    Nihon Geka Gakkai Zasshi; 1984 Mar; 85(3):191-205. PubMed ID: 6236358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinopeptide A during normal pregnancy.
    Romero R; Rickles FR; Matthews E; Scott D; Dinan C; Duffy T
    Am J Perinatol; 1988 Jan; 5(1):70-3. PubMed ID: 3257391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
    Mombelli G; Monotti R; Haeberli A; Straub PW
    Thromb Haemost; 1987 Aug; 58(2):758-63. PubMed ID: 3672428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinopeptide A in plasma of normal subjects and patients with disseminated intravascular coagulation and systemic lupus erythematosus.
    Cronlund M; Hardin J; Burton J; Lee L; Haber E; Bloch KJ
    J Clin Invest; 1976 Jul; 58(1):142-51. PubMed ID: 932202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity.
    Nossel HL; Ti M; Kaplan KL; Spanondis K; Soland T; Butler VP
    J Clin Invest; 1976 Nov; 58(5):1136-44. PubMed ID: 993337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen survival and fibrinopeptide A in acute leukemia.
    Castaman G; Galloni E; Dri AV; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):52-6. PubMed ID: 8039760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of septic pelvic thrombophlebitis by measurement of fibrinopeptide A.
    Weiner CP; Kwaan H; Duboe F
    Am J Perinatol; 1985 Apr; 2(2):93-5. PubMed ID: 4096764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Coagulation-fibrinolysis abnormalities in acute stage of subarachnoid hemorrhage (Part 1)--With special reference to the relation between cerebral vasospasm and fibrinopeptides A and B beta].
    Touho H; Hino A; Suzuki K; Kubo T; Hirakawa K
    No To Shinkei; 1984 Oct; 36(10):1009-14. PubMed ID: 6518124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory application of radioimmunoassay in the quantitation of molecular markers of hemostatic activation.
    Walenga JM; Fareed J; Hoppensteadt D
    Semin Thromb Hemost; 1984 Oct; 10(4):294-305. PubMed ID: 6240117
    [No Abstract]   [Full Text] [Related]  

  • 19. Measurement of fibrinopeptide A in the evaluation of heparin activity and fibrin formation during hemodialysis.
    Wilhelmsson S; Asaba H; Gunnarsson B; Kudryk B; Robinson D; Bergström J
    Clin Nephrol; 1981 May; 15(5):252-8. PubMed ID: 7249422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of plasma fibrinopeptide A (fpA) in patients with malignancy.
    Peuscher FW; Cleton FJ; Armstrong L; Stoepman-van Dalen EA; van Mourik JA; van Aken WG
    J Lab Clin Med; 1980 Jul; 96(1):5-14. PubMed ID: 7391657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.